Taneja Neelam, Mohan Balvinder, Khurana Sumeeta, Sharma Meera
Department of Medical Microbiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Indian J Med Res. 2004 Jul;120(1):39-43.
BACKGROUND & OBJECTIVES: The resistance of enteropathogenic bacteria to commonly prescribed antibiotics is increasing both in developing as well as in developed countries. Resistance has emerged even to newer, more potent antimicrobial agents. The present study was therefore undertaken to report the current antibiotic resistance in common bacterial enteropathogens isolated in a tertiary care hospital in north India.
Faecal samples from 1802 patients were cultured for common bacterial enteropathogens and identified by standard methods. Antibiotic susceptibility was done by Stoke's disk diffusion method. The clinical and demographic profile of the patients was noted.
Stool specimens from 119 (88 male, 31 female) patients yielded Shigella, Salmonella, Vibrio cholerae or Aeromonas. Fifty two per cent (62/119) of patients were children and 70 per cent were below the age of 5 yr. Twenty seven patients developed hospital acquired diarrhoea. Among all enteropathogens, Shigella spp. was the commonest followed by non-typhoidal Salmonella (27), V. cholerae O1 El tor serotype Ogawa (19), Aeromonas spp. (14), Salmonella Typhi and S. paratyphi A (2 isolates each). Resistance to antimicrobial agents was common among all pathogens. Among shigellae an overall resistance of 63.6, 58.1 and 16.3 per cent was observed for nalidixic acid, cotrimoxazole and furazolidone respectively. Seven isolates of Shigella were resistant to ciprofloxacin, (18.5%) of non-typhoidal salmonellae were resistant to ciprofloxacin. V. cholerae were generally susceptible to tetracycline (only 1 isolate out of 13 resistant) and other drugs except nalidixic acid (89.5% resistance) and cotrimoxazole (77.8% resistance).
INTERPRETATION & CONCLUSION: Enteropathogens have developed high level resistance to first line agents used for empiric treatment of diarrhoea. Progressively increasing resistance to ciprofloxacin is a serious cause of concern.
在发展中国家和发达国家,肠道致病菌对常用抗生素的耐药性均在增加。甚至对更新、更强效的抗菌药物也出现了耐药性。因此,本研究旨在报告印度北部一家三级护理医院分离出的常见细菌性肠道致病菌的当前抗生素耐药情况。
对1802例患者的粪便样本进行常见细菌性肠道致病菌培养,并通过标准方法进行鉴定。采用斯托克斯纸片扩散法进行抗生素敏感性检测。记录患者的临床和人口统计学资料。
119例(88例男性,31例女性)患者的粪便标本培养出志贺菌属、沙门菌属、霍乱弧菌或气单胞菌属。52%(62/119)的患者为儿童,70%的患者年龄在5岁以下。27例患者发生医院获得性腹泻。在所有肠道致病菌中,志贺菌属最为常见,其次是非伤寒沙门菌(27例)、霍乱弧菌O1埃尔托型小川血清型(19例)、气单胞菌属(14例)、伤寒沙门菌和甲型副伤寒沙门菌(各2例)。所有病原体对抗菌药物的耐药情况均较为常见。在志贺菌中,萘啶酸、复方新诺明和呋喃唑酮的总体耐药率分别为63.6%、58.1%和16.3%。7株志贺菌对环丙沙星耐药,18.5%的非伤寒沙门菌对环丙沙星耐药。霍乱弧菌通常对四环素敏感(13株中仅1株耐药),对萘啶酸(耐药率89.5%)和复方新诺明(耐药率77.8%)以外的其他药物也敏感。
肠道致病菌对用于腹泻经验性治疗的一线药物已产生高度耐药性。对环丙沙星耐药性的逐渐增加是一个严重的问题。